Biblio

Export 223 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Title is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
J. Goossens, Laton, J., Van Schependom, J., Gielen, J., Struyfs, H., Van Mossevelde, S., Van den Bossche, T., Goeman, J., De Deyn, P. Paul, Sieben, A., Martin, J. - J., Van Broeckhoven, C., van der Zee, J., Engelborghs, S., and Nagels, G., “EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
V. Giannouli, Stamovlasis, D., and Tsolaki, M., “Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1579-1594, 2018.
G. Giaccone, “The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.”, J Alzheimers Dis, 2015.
A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
J. María García-Alberca, Gris, E., de la Guía, P., Mendoza, S., and de la Rica, M. López, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
F
K. Steen Frederiksen, Gjerum, L., Waldemar, G., and Hasselbalch, S. Gregers, “Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.”, J Alzheimers Dis, vol. 61, no. 1, pp. 359-372, 2018.
H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., “Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
T. Fleiner, Leucht, S., Förstl, H., Zijlstra, W., and Haussermann, P., “Effects of Short-Term Exercise Interventions on Behavioral and Psychological Symptoms in Patients with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1583-1594, 2017.
R. Ferrari, Grassi, M., Graziano, F., Palluzzi, F., Archetti, S., Bonomi, E., Bruni, A. C., Maletta, R. G., Bernardi, L., Cupidi, C., Colao, R., Rainero, I., Rubino, E., Pinessi, L., Galimberti, D., Scarpini, E., Serpente, M., Nacmias, B., Piaceri, I., Bagnoli, S., Rossi, G., Giaccone, G., Tagliavini, F., Benussi, L., Binetti, G., Ghidoni, R., Singleton, A., Hardy, J., Momeni, P., Padovani, A., and Borroni, B., “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
M. Fernández-Matarrubia, Matías-Guiu, J. A., Cabrera-Martín, M. Nieves, Moreno-Ramos, T., Valles-Salgado, M., Carreras, J. Luis, and Matías-Guiu, J., “Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1251-1264, 2017.
F. Fan, Liu, H., Shi, X., Ai, Y., Liu, Q., and Cheng, Y., “The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1195-1204, 2022.
V. Andrew Fajardo, Fajardo, V. Andrei, LeBlanc, P. J., and MacPherson, R. E. K., “Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.”, J Alzheimers Dis, vol. 61, no. 1, pp. 425-434, 2018.
E
J. Eugenín, Vecchiola, A., Murgas, P., Arroyo, P., Cornejo, F., and von Bernhardi, R., “Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 857-73, 2016.
M. Ettcheto, Petrov, D., Pedrós, I., Alva, N., Carbonell, T., Beas-Zarate, C., Pallas, M., Auladell, C., Folch, J., and Camins, A., “Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 233-51, 2016.
K. I. Erickson, Voss, M. W., Prakash, R. Shaurya, Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., and Kramer, A. F., “Exercise training increases size of hippocampus and improves memory.”, Proc Natl Acad Sci U S A, vol. 108, no. 7, pp. 3017-22, 2011.
K. H. Elverman, Paitel, E. R., Figueroa, C. M., McKindles, R. J., and Nielson, K. A., “Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1413-1428, 2021.
J. A. Elman, Schork, N. J., and Rangan, A. V., “Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.”, J Alzheimers Dis, vol. 100, no. 4, pp. 1209-1226, 2024.
D
B. Dubois, “The Emergence of a New Conceptual Framework for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1059-1066, 2018.
M. Domínguez-Prieto, Velasco, A., Tabernero, A., and Medina, J. M., “Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1109-1124, 2018.
C. M. Dengler-Crish, Smith, M. A., and Wilson, G. N., “Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1605-1619, 2017.
E. De Lorenzi, Chiari, M., Colombo, R., Cretich, M., Sola, L., Vanna, R., Gagni, P., Bisceglia, F., Morasso, C., Lin, J. S., Lee, M., McGeer, P. L., and Barron, A. E., “Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1213-1226, 2017.
S. M. de la Monte, Tong, M., Daiello, L. A., and Ott, B. R., “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
R. David, Manera, V., Fabre, R., Pradier, C., Robert, P., and Tifratene, K., “Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1365-73, 2016.
V. E Daniel, Kleiman, M. J., and Galvin, J. E., “Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.”, J Alzheimers Dis, vol. 91, no. 1, pp. 495-506, 2023.
G. D'Onofrio, Panza, F., Sancarlo, D., Addante, F., Solfrizzi, V., Cantarini, C., Mangiacotti, A., Lauriola, M., Cascavilla, L., Paris, F., Lozupone, M., Daniele, A., Greco, A., and Seripa, D., “Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.”, J Alzheimers Dis, vol. 62, no. 2, pp. 699-711, 2018.

Pages